Holen Sie sich die Stockscreener-App
11.78
8.96%
-1.16
Handel nachbörslich:
11.78
Schlusskurs vom Vortag:
$12.94
Offen:
$12.94
24-Stunden-Volumen:
61,412
Relative Volume:
0.69
Marktkapitalisierung:
$146.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-11.33
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
-9.38%
1M Leistung:
-23.95%
6M Leistung:
+69.25%
1J Leistung:
+181.82%
1-Tages-Spanne:
$11.58
$13.46
1-Wochen-Bereich:
$11.58
$15.10
52-Wochen-Spanne:
$4.12
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
11.78 | 160.88M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short Interest - MarketBeat
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences - Bluefield Daily Telegraph
Forte Bio (NASDAQ: FBRX) to present at Guggenheim, TD Cowen, Evercore in Nov-Dec - Stock Titan
How Forte Biosciences Inc. stock performs after earningsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com
Why Forte Biosciences Inc. stock appeals to analystsSell Signal & Precise Swing Trade Entry Alerts - newser.com
Signal strength of Forte Biosciences Inc. stock in tech scannersJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Is Forte Biosciences Inc. stock affected by interest rate hikes2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Why Forte Biosciences Inc. stock is in analyst buy zone2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Forte Biosciences, Inc. $FBRX Stake Boosted by AlphaQuest LLC - Defense World
What analyst consensus implies for Forte Biosciences Inc. (37T) stockPortfolio Risk Summary & Reliable Entry Point Trade Alerts - newser.com
How Forte Biosciences Inc. stock reacts to Fed rate cuts2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Why Forte Biosciences Inc. (37T) stock appeals to dividend investorsPortfolio Return Report & Entry and Exit Point Strategies - newser.com
How strong is Forte Biosciences Inc. stock balance sheetGlobal Markets & AI Enhanced Trading Alerts - newser.com
News impact scoring models applied to Forte Biosciences Inc.July 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com
Smart tools for monitoring Forte Biosciences Inc.’s price action2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
How Forte Biosciences Inc. stock performs in interest rate cyclesPortfolio Performance Summary & Free Long-Term Investment Growth Plans - newser.com
Detecting support and resistance levels for Forte Biosciences Inc.Quarterly Performance Summary & High Yield Equity Trading Tips - newser.com
Forte Biosciences (NASDAQ:FBRX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
What analysts say about Forte Biosciences Inc stockMarket Volatility Update & Free High Impact Stock Picks - earlytimes.in
How to interpret RSI for Forte Biosciences Inc. stockMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Weiss Ratings Reaffirms "Sell (E+)" Rating for Forte Biosciences (NASDAQ:FBRX) - MarketBeat
How Forte Biosciences Inc. stock performs in rate cut cycles2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Investors Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Will Forte Biosciences Inc. stock outperform growth indexesPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):